Citizens Holding (NASDAQ:CIZN – Get Free Report) announced a quarterly dividend on Tuesday, November 26th,NASDAQ Dividends reports. Shareholders of record on Monday, December 16th will be paid a dividend of 0.16 per share by the bank on Tuesday, December 31st. This represents a $0.64 dividend on an annualized basis and a dividend yield of 7.31%. The ex-dividend date is Monday, December 16th.
Citizens has decreased its dividend by an average of 9.1% annually over the last three years.
Citizens Price Performance
Shares of NASDAQ CIZN traded up $0.18 during trading hours on Wednesday, reaching $8.75. The stock had a trading volume of 1,035 shares, compared to its average volume of 5,445. The company has a market cap of $49.35 million, a price-to-earnings ratio of 14.34 and a beta of -0.02. Citizens has a twelve month low of $6.64 and a twelve month high of $10.50. The business’s fifty day moving average is $8.85 and its two-hundred day moving average is $8.48.
Analysts Set New Price Targets
Separately, StockNews.com initiated coverage on Citizens in a report on Monday. They set a “sell” rating on the stock.
Read Our Latest Analysis on Citizens
Citizens Company Profile
Citizens Holding Company operates as the bank holding company for The Citizens Bank of Philadelphia that provides various commercial and personal banking products and services. It offers demand deposits; and savings and time deposit accounts. The company also provides secured and unsecured loans; mortgage loans; single and multi-family housing, farm, residential and commercial construction, and commercial real estate loans; commercial, industrial, and agricultural production loans; and consumer loans, as well as issues letters of credit.
Recommended Stories
- Five stocks we like better than Citizens
- Investing in Commodities: What Are They? How to Invest in Them
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing in Construction Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The 3 Best Fintech Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Citizens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citizens and related companies with MarketBeat.com's FREE daily email newsletter.